Each system has its own characteristics at a country-specific level and cannot be easily changed

Historical developments, traditions and culture have a large influence on the way health systems are organised in a country. Thus, the out-patient and in-patient pharmaceutical systems are the outcome of country-specific characteristics and habits. Cross-country sur-veys are important instruments which allow learning about the challenges and solutions in other countries. Good-practice examples should be identified and studied with a view to adapting such measures in one’s own country. However, these case examples are models and cannot be copied identically, but need to be translated into policy options which take the country-specific framework into consideration. Each health care system and pharma-ceutical system covered in this study has its beneficial and rather unfavourable character-istics: policy changes should target specific deficiencies but should not challenge the sys-tem on the whole.

14 Literature

COWI Report 2009

Analysis of hospital pharmaceuticals. Commissioned by the Danish Ministry of Health and Prevention.

EAHP 2005

Pan European survey on the state of the art and development of hospital pharmacy. In online: http://www.eahp.eu/EAHP-survey

EMINet 2009a

Orphan medicines survey. Vienna (unpublished) EMINet 2009b

Tender system for outpatient pharmaceuticals in the European Union: Evidence from the Netherlands, Germany and Belgium. London (unpublished)

EUROSTAT 2009

Total population on 1 January of each year. In online: http://epp.eurostat.ec.europa.eu/

Fijn, R. 2001

Managing rational pharmacotherapy in hospitals: What about drug formularies and pharma-cotherapeutic guidelines? Groningen, Universal Press, Science Publishers, Veenedaal GÖG/ÖBIG 2006

Analyse des Nahtstellenmanagements bei Arzneimitteln. Vienna 2006 GÖG/ÖBIG 2010

Rational use of medicines in Europe. Executive Summary. Vienna 2010. In online:

http://ppri.goeg.at Æ Publications/GÖG reports HOPE 2006

DRG as a financing tool. Brussels 2006. In online:

http://hope.be/05eventsandpublications/publications_chronologicallist.html HOPE 2009

Hospitals in the 27 Member States of the European Union. La Défense cedex 2009. In online: http://hope.be/05eventsandpublications/publications_chronologicallist.html HOPE 2010

Country profiles, several years. In online: http://www.hope.be/

ÖBIG FP 2008a

Tendering of Pharmaceuticals in EU Member States and EEA countries. Results from the country survey. June 2008. In online: http://ppri.goeg.at Æ Publications/GÖG reports

ÖBIG FP 2008b

Referenzpreissysteme in Europa. Analyse und Umsetzungsvoraussetzungen für Österreich.

February 2008. In online: http://ppri.goeg.at Æ Publications/GÖG reports ÖBIG FP 2009a

Access to essential medicines in Portugal. July 2009. In online: http://ppri.goeg.at Æ Publica-tions/GÖG reports

ÖBIG FP 2009b

Access to essential medicines in Poland. August 2009. In online: http://ppri.goeg.at Æ Publications/GÖG reports

OECD 2000

A System of Health Accounts. Version 1.0. 2000 OECD 2008-2009

Survey on health system characteristics 2008-2009. Paris: OECD OECD 2009

OECD Health Database, 2009 PHARMIG 2008

Daten und Fakten 2006. Vienna: PHARMIG PHIS 2009a

PHIS Glossary. June 2009. Latest update May 2010: In online: http://phis.goeg.at ÆGlossary PHIS 2009b

PHIS Hospital Pharma Methodology Paper, October 2009 (unpublished) PHIS 2009c-u

PHIS Hospital Pharma Reports. Various country reports on pharmaceutical pricing and reimbursement in the in-patient sector under the PHIS (Pharmaceutical Health Information System) project. Accessible at: http://phis.goeg.at Æ Hospital Pharma Æ country information PHIS 2009c

PHIS Hospital Pharma Report Austria 2009 PHIS 2009d

PHIS Hospital Pharma Report Belgium 2009 (unpublished) PHIS 2009e

PHIS Hospital Pharma Report Bulgaria 2009 PHIS 2009f

PHIS Hospital Pharma Report Cyprus 2009

PHIS 2009g

PHIS Hospital Pharma Report Czech Republic 2009 (unpublished) PHIS 2009h

PHIS Hospital Pharma Report Denmark 2009 PHIS 2009i

PHIS Hospital Pharma Report Finland 2009 PHIS 2009j

PHIS Hospital Pharma Report Italy 2009 (unpublished) PHIS 2009k

PHIS Hospital Pharma Report Lithuania 2009 (unpublished) PHIS 2009l

PHIS Hospital Pharma Report Latvia 2009 PHIS 2009m

PHIS Hospital Pharma Report Malta 2009 PHIS 2009n

PHIS Hospital Pharma Report Netherlands 2009 PHIS 2009o

PHIS Hospital Pharma Report Norway 2009 PHIS 2009p

PHIS Hospital Pharma Report Poland 2009 (unpublished) PHIS 2009q

PHIS Hospital Pharma Report Portugal 2009 (unpublished) PHIS 2009r

PHIS Hospital Pharma Report Sweden 2009 (unpublished) PHIS 2009s

PHIS Hospital Pharma Report Slovakia 2009 PHIS 2009t

PHIS Hospital Pharma Report United Kingdom 2009 PHIS 2009u

PHIS Hospital Pharma Report Turkey 2009 PHIS 2009v

PHIS Hospital Pharma Report 2009 – Benchmarking, Information and Data Compilation, European Survey

PHIS 2009w

PHIS Taxonomy. June 2009. In online: http://phis.goeg.at Æ PHIS Database PHIS case studies 2009

Price survey undertaken by GÖG/ÖBIG, SUKL and participating country representatives 2009

PHIS 2010

PHIS Hospital Pharma Seminar – Key messages. Bratislava, 26 February. Accessible at:

http://phis.goeg.at Æ Hospital Pharma PPRI 2007/2008/2009

PPRI Pharma Profiles. Various country reports on pharmaceutical pricing and reimbursement under the PPRI (Pharmaceutical Pricing and Reimbursement Information) project. Accessible at: http://ppri.goeg.at Æ Publications

PPRI 2008

PPRI Report. Pharmaceutical Pricing and Reimbursement Information (PPRI), commissioned by DG SANCO and Austrian Ministry of Health, Women and Consumers. Vienna, June 2008.

Accessible at: http://ppri.goeg.at Æ Publications PPRI 2009

PPRI Pharma Profile Austria 2009 Vogler, S.; Espin, J.; Habl, C. 2009

Pharmaceutical Pricing and Reimbursement Information (PPRI) – New PPRI analysis includ-ing Spain. Pharmaceuticals Policy and Law 11 (2009) 213–234

WHO 2002a

Hospitals in a changing Europe. European Observatory on Health Care Systems Series WHO 2002b

Practical Guidelines on Pharmaceutical Procurement for Countries with Small Procurement Agencies

WHO 2003

Drug and Therapeutics Committees. A Practical Guide. In collaboration with Managing Sciences for Health. Geneva

WHO 2009

Measuring Transparency in the Public Pharmaceutical Sector. Assessment Instrument.

Geneva WHO 2010

Health for All Database, February 2010

15 Annex

In order to save the environment, the print version of the PHIS Pharma Hospital report contains no annexes. All documents of the Annex are included in the electronic version of the report.

Annex I PHIS Glossary. June 2009. Latest updated version as of May 2010 Annex II PHIS Hospital Pharma Report template

Annex III PHIS Hospital Pharma Case Study – Questionnaire

Annex IV PHIS Hospital Pharma Case Study – Price Query Template Annex V Published versions of the country PHIS Hospital Pharma Reports

PHIS Hospital Pharma Report Austria PHIS Hospital Pharma Report Bulgaria PHIS Hospital Pharma Report Cyprus PHIS Hospital Pharma Report Denmark PHIS Hospital Pharma Report Finland PHIS Hospital Pharma Report Latvia PHIS Hospital Pharma Report Malta PHIS Hospital Pharma Report Norway PHIS Hospital Pharma Report Slovakia

PHIS Hospital Pharma Report The Netherlands PHIS Hospital Pharma Report Turkey

PHIS Hospital Pharma Report United Kingdom